$12.5M Class Deal Reached In Ionis-Akcea Drug Licensing Suit
A class of Akcea Therapeutics Inc. stockholders told Delaware Chancery Court on Tuesday that they had reached a $12.5 million settlement with former directors and officers of the company over claims...To view the full article, register now.
Already a subscriber? Click here to view full article